IRadimed Corp (IRMD) stock

IRMDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 19/3059% above fair value

$85.23−1.35 (-1.56%)

Close on Nov 12, 2026Market cap $1.09BP/E 45.6Yield –

IRadimed statistics

102 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings: Feb 9, 2027 (estimated, before the open)
Last ex-dividend date: Nov 13, 2026
Fundamentals through: Sep 30, 2026
Share price as of: Nov 12, 2026

Valuation ratiosIndustry

Market Cap: $1.09B; $501.02M
Enterprise Value: $1.03B; $422.54M
PE Ratio: 45.58; 29.97
PS Ratio: 12.20; 3.03
PB Ratio: 10.24; 3.29
P/TBV Ratio: 10.58; 4.85
P/FCF Ratio: 41.70; 26.37
P/OCF Ratio: 40.15; 22.12

Enterprise valuationIndustry

EV / Sales: 11.49; 2.70
EV / EBITDA: 33.64; 18.53
EV / EBIT: 35.57; 24.04
EV / FCF: 39.28; 27.78

Share statisticsIndustry

Shares Outstanding: 13M; 43M
Shares Change (YoY): 0.27%; 3.22%
Shares Change (QoQ): 0.01%; 0.16%
Float: 8M; 37M
Shares Held by Insiders: 35.5%; 10.5%
Shares Held by Institutions: 61.4%; 60.2%

Short sellingIndustry

Short Interest: 590,054; –
Short Interest Change: -12.0%; -2.57%
Short % of Float: 7.15%; 5.12%
Short % of Shares Outstanding: 4.61%; 3.98%
Days to Cover: 5.10; 3.94

Stock price statisticsIndustry

52-Week High: $107.90; –
52-Week Low: $76.35; –
20-Day Moving Average: $85.34; –
50-Day Moving Average: $85.32; –
200-Day Moving Average: $91.81; –
Average True Range (14): $3.01; –
Price Change (1 Week): -0.36%; 1.87%
Price Change (1 Month): -5.12%; -0.57%
Price Change (3 Months): -1.98%; -7.91%
Price Change (6 Months): -1.91%; -0.90%
Price Change (YTD): -12.4%; -0.87%
Price Change (1 Year): 0.70%; -1.18%
Price Change (3 Years): 104.5%; 6.56%
Price Change (5 Years): 111.5%; -49.8%
Price Change (10 Years): 760.9%; 72.9%
Average Volume (10 Days): 150,799; –
Average Volume (20 Days): 129,085; –
Average Volume (90 Days): 124,090; –
Relative Volume: 0.57; 0.82
Relative Strength Index (14): 49.2; 47.7
Volatility (1 Year): 31.7%; 64.2%
Beta (5 Years): 0.75; 1.04

MarginsIndustry

Gross Margin: 75.5%; 55.9%
Operating Margin: 32.3%; -5.17%
Pretax Margin: 34.8%; -2.55%
Profit Margin: 26.8%; -9.23%
EBITDA Margin: 34.2%; -2.82%
FCF Margin: 29.3%; 0.40%

Returns on capitalIndustry

Return on Equity (ROE): 23.4%; -17.1%
Return on Assets (ROA): 20.3%; -12.2%
Return on Invested Capital (ROIC): 52.3%; -3.22%
Return on Capital Employed (ROCE): 26.1%; -8.13%

Financial positionIndustry

Current Ratio: 8.99; 2.45
Quick Ratio: 7.46; 1.53

GrowthIndustry

Revenue Growth (YoY): 11.0%; 9.24%
Net Income Growth (YoY): 13.2%; 13.4%
EPS Growth (YoY): 13.3%; 15.1%
FCF Growth (YoY): 77.2%; 7.64%
Revenue Growth (3Y CAGR): 16.3%; 7.08%
Revenue Growth (5Y CAGR): 21.5%; 11.8%
EPS Growth (3Y CAGR): 19.7%; 3.11%
EPS Growth (5Y CAGR): 73.9%; 7.64%

EfficiencyIndustry

Asset Turnover: 0.76; 0.59
Inventory Turnover: 1.73; 2.20
Revenue Per Employee: $538.19K; $330.60K
Profits Per Employee: $144.48K; -$41.39K
Employee Count: 166; 186
WACC: 8.73%; 9.79%

Income statement (TTM)Industry

Revenue: $89.34M; $106.81M
Gross Profit: $67.46M; $62.29M
Operating Income: $28.86M; -$3.72M
Pretax Income: $31.12M; -$1.69M
Net Income: $23.98M; -$6.19M
EBITDA: $30.52M; -$1.98M
EPS (Diluted): $1.87; -$0.08

Balance sheetIndustry

Cash & Short-Term Investments: $63.29M; $38.08M
Net Cash (Debt): $63.29M; $3.73M
Net Cash Per Share: $4.95; $0.24
Equity (Book Value): $106.45M; $63.44M
Book Value Per Share: $8.32; $3.26
Tangible Book Value: $103.04M; $11.04M
Working Capital: $82.48M; $56.85M

Cash flow (TTM)Industry

Operating Cash Flow: $27.15M; -$541.49K
Capital Expenditures: -$1.01M; -$3.69M
Free Cash Flow: $26.14M; -$387.37K
FCF Per Share: $2.04; -$0.01

Dividends and yieldsIndustry

Earnings Yield: 2.20%; -4.70%
FCF Yield: 2.40%; 0.24%
Payout Ratio: 67.6%; 24.3%
FCF Payout Ratio: 62.1%; 22.0%

Taxes and interestIndustry

Income Tax: $7.13M; $1.63M
Effective Tax Rate: 22.9%; 18.3%

Scores and fair valueIndustry

Graham Number: $18.71; $38.11
Graham Upside: -78.0%; -56.6%
Altman Z-Score: 47.94; 2.44
Piotroski F-Score: 6; 5
Beneish M-Score: -2.55; -2.64
Lynch Fair Value: $46.75; –
Lynch Upside: -45.1%; -45.1%

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.

Period	IRMD	S&P 500	Difference	IRMD per year	S&P 500 per year
1 month	-4.7%	-2.7%	−2.0 pts
3 months	-2.3%	-1.7%	−0.5 pts
Year to date	-11.8%	+11.9%	−23.7 pts
1 year	-0.0%	+12.0%	−12.0 pts
3 years	+125.5%	+78.2%	+47.3 pts	+31.1%	+21.2%
5 years	+132.9%	+73.2%	+59.7 pts	+18.4%	+11.6%
10 years	+848.0%	+309.6%	+538.3 pts	+25.2%	+15.1%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

1M IRMD shares were sold short on Oct 30, 2026, down 12.0% from the previous report, or 7.15% of the shares available to trade. At recent volumes it would take 5.1 days to buy them back. Over the last 20 sessions, 48.2% of the volume reported to FINRA was short selling.

Settlement date	Shares short	Change	Avg. daily volume	Days to cover
Oct 30, 2026	590,054	-12.0%	115,775	5.1
Oct 15, 2026	670,183	+1.9%	108,451	6.2
Sep 30, 2026	657,367	-6.1%	146,217	4.5
Sep 15, 2026	700,005	+0.4%	122,798	5.7
Aug 31, 2026	697,251	-4.2%	83,253	8.4
Aug 14, 2026	727,749	+8.6%	150,656	4.8
Jul 31, 2026	670,183	-5.1%	116,157	5.8
Jul 15, 2026	705,832	+2.9%	140,576	5.0
Jun 30, 2026	685,974	+0.6%	141,364	4.8
Jun 15, 2026	681,716	+4.4%	154,198	4.4
May 29, 2026	652,970	-1.2%	156,280	4.2
May 15, 2026	661,120	+20.9%	119,480	5.5